您的购物车当前为空
Zosuquidar trihydrochloride (LY-335979 trihydrochloride) 是一种高选择性、强效的 P - 糖蛋白(P-gp, ABCB1)竞争性抑制剂,Ki 值为 59 nM。Zosuquidar trihydrochloride 具有抗肿瘤活性,可用于白血病等肿瘤研究。
别名 唑喹达三盐酸盐, Zosuquidar 3HCl, Zosuquidar (LY335979) 3HCl, RS 33295-198 trihydrochloride, RS 33295-198 (D06387) 3HCl, LY-335979 trihydrochloride
Zosuquidar trihydrochloride (LY-335979 trihydrochloride) 是一种高选择性、强效的 P - 糖蛋白(P-gp, ABCB1)竞争性抑制剂,Ki 值为 59 nM。Zosuquidar trihydrochloride 具有抗肿瘤活性,可用于白血病等肿瘤研究。

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 315 | 现货 | |
| 2 mg | ¥ 449 | 现货 | |
| 5 mg | ¥ 745 | 现货 | |
| 10 mg | ¥ 1,070 | 现货 | |
| 25 mg | ¥ 1,790 | 现货 | |
| 50 mg | ¥ 2,650 | 现货 | |
| 100 mg | ¥ 3,980 | 现货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | Zosuquidar trihydrochloride (LY-335979 trihydrochloride) is a highly selective, potent competitive inhibitor of P-glycoprotein (P-gp, ABCB1) with a Ki value of 59 nM. Zosuquidar trihydrochloride exhibits antitumor activity and can be used in research on tumors such as leukemia. |
| 靶点活性 | MDR:6 μM-16 μM, SW620 cells:0.059 μM, P-gp:60 nM (Ki) |
| 体外活性 | 方法:在 P-gp 高表达的细胞系中加入 P-gp 抑制剂 Zosuquidar trihydrochloride (0.3 μM),同时加入 AVE9633 或 DM4 (3.125, 6.25, 12.5, 25, 50, 100 and 200 nM),AVE9633 处理 4 天,DM4 处理 3 天。单层细胞外排实验检测 P-gp 抑制。 |
| 体内活性 | 方法:野生型小鼠通过颈动脉插管,以恒定流速(2.5 mL/min)向大脑灌注含有药物(imatinib, 0.05 - 50 μM; Zosuquidar trihydrochloride, 0.5 μM)的生理缓冲液。灌注结束后,立即处死小鼠,取脑组织测定药物浓度,计算脑摄取率。 |
| 激酶实验 | ATPase Assay : P-Glycoprotein ATPase activity is measured by the liberation of inorganic phosphate from ATP. The assay is measured in a 96-well plate for 90 min at 37 °C. Membranes (8 μg-10 μg protein) are incubated in a total volume of 100 μL of buffer A containing 5 mM sodium azide, 1 mM ouabain, 1 mM EGTA, 3 mM ATP, an ATP regenerating system composed of 5 mM phosphoenolpyruvate, and 3.6 units/mL pyruvate kinase in the presence and absence of 1 mM sodium vanadate. Pgp-ATPase activity is defined as the vanadate-sensitive portion of the total ATPase activity. Plates are read 3 minutes after the addition of the detection solution. The absorbance is measured at 690 nm by a microtiter dish reader. A phosphate standard curve is used to calculate the μMol of phosphate formed. Samples are measured in triplicate. |
| 细胞实验 | Cell viability is determined using a modified 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide dye reduction method. Cells are harvested during logarithmic growth phase, and seeded in 96-well plates. The cells are then cultured for 72 hours in the presence of oncolytics with or without modulators. MCF-7 and MCF-7/ADR cells are incubated 24 hours before the addition of the drug with and without the LY335979. LY335979 is prepared as 2 mM DMSO stocks and added to wells to give final concentrations ranging from 0.05 to 5 μM. After 72 hours, 20 μL of freshly prepared 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (5 mg/mL in Dulbecco's PBS) is added to each well and incubated for 4 hours in a 37 °C incubator containing 5% CO2. Cells are pelleted in a Sorvall RT6000B centrifuge, 70 μL of medium is carefully removed from each well, and 100 μL of 2-propanol/0.04 N HC1 is added. Cells are resuspended 5-10 times with a Multipipettor or until no particulate matter is visible. Plates are immediately read on a Titertek Multiskan MCC/340 microplate reader Flow Laboratories with a test wavelength of 570 nm and a reference wavelength of 630 nm. Controls are measured in quadruplicate and modulators are measured in duplicate. Cytotoxicity analyses are also performed using the CeliTiter 96 AQueous assay kit.(Only for Reference) |
| 别名 | 唑喹达三盐酸盐, Zosuquidar 3HCl, Zosuquidar (LY335979) 3HCl, RS 33295-198 trihydrochloride, RS 33295-198 (D06387) 3HCl, LY-335979 trihydrochloride |
| 分子量 | 636.99 |
| 分子式 | C32H31F2N3O2·3HCl |
| CAS No. | 167465-36-3 |
| Smiles | FC1([C@@]2([H])[C@]1([H])C3=CC=CC=C3[C@H](N4CCN(CC4)C[C@@H](O)COC5=CC=CC6=C5C=CC=N6)C7=CC=CC=C72)F.Cl.Cl.Cl |
| 密度 | no data available |
| 存储 | Store under nitrogen Powder: -20°C for 3 years Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80.83 mg/mL (126.89 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | ||||||||||||||||||||||||||||||||||||

Zosuquidar and UIC2 Fab complex of human-mouse chimeric ABCB1 (ABCB1HM)
对于不同动物的给药剂量换算,您也可以参考 更多